Adaptive Randomization of Neratinib in Early Breast Cancer

N Engl J Med. 2016 Oct 20;375(16):1591-2. doi: 10.1056/NEJMc1609993.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Humans
  • Quinolines / therapeutic use
  • Random Allocation*
  • Receptor, ErbB-2

Substances

  • Quinolines
  • Receptor, ErbB-2